Ipsen receives CHMP positive opinions for Iqirvo in Primary Biliary Cholangitis and Kayfanda in Alagille Syndrome, two rare cholestatic liver diseases

Press/Media: Expert Comment › Popular

Period	29-Jul-2024

Media coverage

Title	Ipsen receives CHMP positive opinions for Iqirvo in Primary Biliary Cholangitis and Kayfanda in Alagille Syndrome, two rare cholestatic liver diseases
Degree of recognition	International
Media name/outlet	MarketScreener
Media type	Web
Date	29/07/2024
URL	https://www.marketscreener.com/quote/stock/IPSEN-5137/news/Ipsen-receives-CHMP-positive-opinions-for-Iqirvo-in-Primary-Biliary-Cholangitis-and-Kayfanda-in-Alag-47492011/
Persons	Henkjan Verkade